New Zealand remains concerned over animal health merger
New Zealand’s antitrust watchdog has reiterated its concerns that animal health company Zoetis’ proposed acquisition of Jurox will harm competition for certain pre-anesthetics and sedatives for cats and dogs.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.